Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.

× No keyword cloud information.

9 in total

1. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.

Authors: A B Lang; E Fürer; J W Larrick; S J Cryz
Journal: Infect Immun Date: 1989-12 Impact factor: 3.441

Review 2. Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance.

Authors: Chongbing Liao; Xin Huang; Qingxia Wang; Dan Yao; Wuyuan Lu
Journal: Front Cell Infect Microbiol Date: 2022-07-06 Impact factor: 6.073

3. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

Authors: B J Appelmelk; Y Q An; B G Thijs; D M MacLaren; J de Graaff
Journal: Infect Immun Date: 1994-08 Impact factor: 3.441

4. Lactoferrin is a lipid A-binding protein.

Authors: B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal: Infect Immun Date: 1994-06 Impact factor: 3.441

Review 5. Vaccines for Pseudomonas aeruginosa: a long and winding road.

Authors: Gregory P Priebe; Joanna B Goldberg
Journal: Expert Rev Vaccines Date: 2014-02-27 Impact factor: 5.217

6. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.

Authors: S J Cryz; J C Sadoff; E Fürer
Journal: Infect Immun Date: 1988-07 Impact factor: 3.441

A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.

1. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.

Review 2. Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance.

3. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

4. Lactoferrin is a lipid A-binding protein.

Review 5. Vaccines for Pseudomonas aeruginosa: a long and winding road.

6. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.

7. Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.

8. Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.

Review 9. Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.